Estrogen and anti-androgen therapy will slow facial hair growth and make it finer, but it won’t fully eliminate existing beard hair for most trans women. In a survey of nearly 1,000 gender minority patients, 84% of trans women on feminizing hormone therapy still reported excess facial hair. The hormones do real work, reducing the density, thickness, and growth rate of facial hair over time, but the terminal hair follicles that were already activated by testosterone are stubbornly resistant to reversal. Most trans women need laser hair removal, electrolysis, or both to achieve the results they want.
How Hormones Affect Hair Follicles
Facial hair exists because testosterone and its more potent form, DHT, bind to receptors inside the dermal papilla cells of hair follicles. These androgens convert the fine, nearly invisible vellus hairs on your face into thick, dark terminal hairs. An enzyme called 5-alpha reductase, located within the hair follicle itself, handles that conversion from testosterone to DHT.
Estradiol works against this process in a few ways. It binds to estrogen receptors in the hair follicle, directly influencing the growth cycle. It also affects local androgen metabolism within the follicle. Meanwhile, anti-androgens block testosterone from reaching those receptors or suppress its production altogether. The combination lowers the hormonal signal that tells follicles to keep producing coarse hair.
The problem is that once a follicle has been converted to terminal status, it doesn’t easily revert. Terminal-to-vellus conversion (called follicular miniaturization) does happen in some contexts, like female pattern hair loss on the scalp, but facial hair follicles are particularly resistant. They’ve been structurally remodeled by years of androgen exposure, and removing the androgen signal slows them down without fully shutting them off.
What Changes You Can Expect
According to Johns Hopkins Medicine, decreased terminal hair growth typically begins 6 to 12 months after starting feminizing hormone therapy, with maximum effect taking more than 3 years. A systematic review of the research found statistically significant decreases in hair length, diameter, and density, though the authors noted that very few studies used precise quantitative measurements.
In practical terms, you’ll likely notice that your facial hair grows more slowly, the individual hairs become thinner and lighter, and you may need to shave less often. One study found that about 56% to 71% of adolescents on feminizing therapy reported decreased shaving frequency. Among adults taking a specific anti-androgen, about 28% reported noticeably decreased facial hair. These numbers vary widely because individual response depends on genetics, age at starting hormones, and how effectively testosterone is suppressed.
UCSF’s clinical guidelines are blunt about expectations: feminizing hormone therapy produces a reduction of body hair and, to a lesser extent, facial hair. The face is the hardest area to see improvement.
Why Facial Hair Persists
Multiple studies have documented that facial hair persists even after years of hormone therapy with full androgen suppression. One long-term study found decreased facial and truncal hair growth overall, but specifically noted that facial hair persisted. This finding has been replicated enough times that researchers consider it a consistent limitation of hormone therapy alone.
The likely explanation is that facial hair follicles have an unusually high density of androgen receptors and are especially sensitive to even small amounts of circulating androgens. Even with testosterone suppressed below 50 ng/dL (the clinical target for trans women), trace amounts still reach these follicles. The follicles themselves also contain 5-alpha reductase, meaning they can locally produce DHT from whatever testosterone is available.
Medications That May Help Further
Some prescribers add a 5-alpha reductase inhibitor to the standard estrogen and anti-androgen regimen. These medications block the enzyme that converts testosterone into DHT within the follicle. UCSF notes they can be useful for trans women who continue to show virilized features even after complete androgen blockade, though their effect is more modest than full testosterone suppression since they don’t block testosterone itself.
Starting hormones earlier, particularly before or during puberty, means fewer follicles have been activated by testosterone in the first place. Trans women who begin feminizing therapy as adolescents generally have less established facial hair to contend with, which is one reason results vary so much between individuals.
Why Most Trans Women Need Hair Removal
The clinical consensus is clear: routine feminizing hormone therapy is not sufficient to fully eliminate unwanted facial hair. That survey of nearly 1,000 patients found that the vast majority of trans women on hormones still dealt with excess hair, leading the researchers to call for better insurance coverage of laser hair removal and electrolysis.
Laser hair removal works by targeting the pigment in dark hair follicles with concentrated light, damaging them enough to prevent regrowth. It’s most effective on dark hair against lighter skin, though newer laser types work on a broader range of skin tones. Laser can significantly reduce hair volume but often doesn’t catch every follicle, especially lighter ones.
Electrolysis destroys individual follicles with an electric current delivered through a tiny probe. It’s the only method considered truly permanent by the FDA and works on all hair colors and skin types. The tradeoff is that it’s slow, treating one follicle at a time, and typically requires many sessions over months or years for a full beard area.
Many trans women use both methods: laser first to knock out the bulk of dark hair quickly, then electrolysis to clean up remaining lighter or finer hairs. Starting hair removal early in transition, even alongside hormone therapy, saves time since the two approaches work through completely different mechanisms. Hormones slow new growth and thin existing hair, while laser and electrolysis permanently destroy the follicles that hormones can’t fully shut down. Cost remains the biggest barrier, with both methods typically requiring significant out-of-pocket expense, though insurance coverage is slowly expanding.